<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>22269836</identifier>
<setSpec>1885-5857</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cordero, Alberto</dc:author>
<dc:author>Lekuona, Iñaki</dc:author>
<dc:author>Galve, Enrique</dc:author>
<dc:author>Mazón, Pilar</dc:author>
<dc:description xml:lang="en">In 2011, the importance of hypertension and diabetes mellitus as the two main risk factors responsible for the development of cardiovascular disease became clear, as did their significance as major public health issues. Compared with previous years, in which publication of the results of large clinical trials dominated scientific progress, in the last year, the focus has shifted to evidence that novel mechanisms associated with blood pressure, glucose metabolism and diabetes can influence cardiovascular disease. Of particular importance were clinical trials in the area of renal dysfunction, such as the SHARP and ROADMAP trials.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2012 Jan </dc:date>
<dc:title xml:lang="es">Novedades en hipertensión arterial y diabetes mellitus.</dc:title>
<dc:title xml:lang="en">[Advances in arterial hypertension and diabetes mellitus].</dc:title>
<dc:publisher>Revista espanola de cardiologia (English ed.)</dc:publisher>
</metadata>
</record>
</pubmed-document>
